Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Leukemia & Lymphoma|May 26, 1999
CD5+ persistent polyclonal B-cell lymphocytosis in a maleC B Reeder, C R ConleyMayo Clinic Proceedings|December 1, 1991
The evolution of Hodgkin's disease and necrobiotic xanthogranuloma syndromeC B Reeder, S M Connolly, R K WinkelmannBone Marrow Transplantation|August 30, 2011
Stem cell transplant for Waldenström macroglobulinemia: an underutilized techniqueM A Gertz, C B Reeder, R A Kyle, et al.Mayo Clinic Proceedings|February 13, 1999
Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpuraK L Harold, R T Schlinkert, D K Mann, et al.Blood Cancer Journal|January 16, 2016
Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?A Rosenthal, J Luthi, M Belohlavek, et al.Archives of Pathology & Laboratory Medicine|November 11, 1992
Eosinophil-mediated bile duct stricture. A case studied by immunohistochemistryR T Schlinkert, M de la Garza-Grahm, C B Reeder, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2013
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 studyP L Zinzani, J M Vose, M S Czuczman, et al.Leukemia|August 2, 2001
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemiaA Tefferi, C Y Li, C B Reeder, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphomaT E Witzig, J M Vose, P L Zinzani, et al.Leukemia|December 8, 2010
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphomaT E Witzig, C B Reeder, B R LaPlant, et al.Pageof 2